Merck Leaps Into COVID-19 Development Fray with Vaccine, Drug Deals
Most big pharmaceutical companies have already placed their bets on COVID-19 treatments, but Merck has been waiting for opportunities with proven track recordsActualités similaires
Articles similaires à Merck Leaps Into COVID-19 Development Fray with Vaccine, Drug Deals
The Infodemic: FDA Didn't Say Pfizer Vaccine Dose Dorrelated with Increased COVID-19 Infections
Fake news about the coronavirus can do real harm. Polygraph.info is spotlighting fact-checks from other reliable sources here .Actualités similaires
US Drug Maker Merck to Help Produce Rival's COVID Vaccine
Agreement could ease Johnson & Johnson's slowed productionActualités similaires
Britain Drug Regulatory Agency Approves Second COVID-19 Vaccine for Emergency Use
Vaccine developed by AstraZeneca-Oxford likely to be available across Britain within days; Chinese state-run drug maker seeks regulatory approval after ...Thai Firm Joins with AstraZeneca to Make COVID-19 Vaccine for Southeast Asia
Thailand says most of the 200 million doses the British pharmaceutical firm plans to churn out of a local lab will go to neighboring countriesActualités similaires
US Drug Maker Moderna Announces Experimental COVID-19 Vaccine is More than 90% Effective Against Virus
The news comes just a week after a joint effort by US-based Pfizer and German-based BioNTech announced a breakthroughActualités similaires
Experimental COVID-19 Therapeutic Drug No Help to Patients with Advanced Stage of Virus
Trial of potential therapeutic drug paused earlier this month due to safety concerns //Actualités similaires
EU Contracts with Johnson & Johnson on Possible COVID-19 Vaccine
Announcement comes in light of fresh spike across Europe forcing countries to reintroduce previously relaxed COVID-19 restrictions, including shutdown of bars, ...Actualités similaires
US Drug Oversight Agency Issues New Guidelines on COVID-19 Vaccine Approval//
Rules formed by US Food and Drug Administration likely would push approval of potential vaccine past November 3 presidential electionActualités similaires
The Infodemic: US Didn't Sanction Russia for COVID-19 Vaccine Development
Fake news about the coronavirus can do real harm. Polygraph.info is spotlighting fact-checks from other reliable sources here .Actualités similaires
US Government Drug Agency Considering Stricter New Guidelines on Approval for COVID-19 Vaccine
If new guidelines adopted by US Food and Drug Administration, emergency authorization of new vaccine could come well after November 3 presidential election, ...Biden Counters Trump With COVID-19 Vaccine Delivery Plan of His Own
Democratic Party's challenger for presidency rolls out his plan hours after US government outlined its strategy for deploying coronavirus vaccine dosesActualités similaires
COVID-19 Vaccine Development Will Follow Scientific Process, US Experts Vow
Top health officials tell Senate vaccine candidates currently in large-scale US trials are expected to deliver a result that can be distributed to most ...Actualités similaires
COVID-19 Crisis Won't Necessarily End With Vaccine, WHO Says
Europe Director Hans Kluge says societies need to learn to live with virusActualités similaires
COVID-19 Crisis Won't Necessarily End With Vaccine, WHO Chief Says
Europe Director Hans Kluge says societies need to learn to live with virusUS Makes Deal with Biotech Company for 100 Million Doses of Potential COVID-19 Vaccine
Trump's announcement comes hours after Russia announced formal approval of a coronavirus vaccineMerck Leaps Into COVID-19 Development Fray with Vaccine, Drug Deals
Most big pharmaceutical companies have already placed their bets on COVID-19 treatments, but Merck has been waiting for opportunities with proven track recordsActualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
